Apellis Pharmaceuticals Inc (APLS)
Apellis and Sobi Announce EMPAVELI®(pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
Apellis and Sobi Announce EMPAVELI®(pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
There are no comments here yet...